Møller, Bjørn Leth http://orcid.org/0009-0008-3007-4007
Lo, Bobby Zhao Sheng
Burisch, Johan
Bendtsen, Flemming
Vind, Ida
Ibragimov, Bulat
Igel, Christian
Funding for this research was provided by:
BETA.HEALTH (1260)
Novo Nordisk Fonden (NNF20OC0062056)
Article History
Received: 23 June 2023
Accepted: 2 November 2023
First Online: 21 February 2024
Declarations
:
: Bobby Lo reports an unrestricted grant from Beta. Health related to the submitted work and advisory/consultant fee from Tillotts Pharma, Bristol-Myers Squibb, Paratech A/S; Teaching fee from Tillotts Pharma, Janssen Cilag; Research grant from Tillotts Pharma, Janssen Cilag, Takeda, Abbvie. Dr. Burisch reports grants and personal fees from AbbVie, grants and personal fees from Janssen-Cilag, personal fees from Celgene, grants and personal fees from MSD, personal fees from Pfizer, grants and personal fees from Takeda, grants and personal fees from Tillots Pharma, personal fees from Samsung Bioepis, grants and personal fees from Bristol Myers Squibb, grants from Novo Nordisk, personal fees from Pharmacosmos, personal fees from Ferring, personal fees from Galapagos, outside the submitted work. Doctor Bendtsen reports consulting fees, lecture fees or research funds from Takeda Pharma A/S, Norgine Danmark A/S, Ferring Pharmaceuticals A/S. No other authors have anything to report.